Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.7%

2 terminated out of 30 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

10%

3 trials in Phase 3/4

Results Transparency

20%

3 of 15 completed with results

Key Signals

3 with results88% success

Data Visualizations

Phase Distribution

26Total
Not Applicable (16)
P 1 (3)
P 2 (4)
P 3 (1)
P 4 (2)

Trial Status

Completed15
Unknown6
Recruiting3
Suspended2
Terminated2
Not Yet Recruiting1

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (30)

Showing 20 of 20 trials
NCT07544524Not ApplicableRecruiting

Feasibility, Safety and Efficacy of a Predominantly Plant-based Diet in an Asian Population With Chronic Kidney Disease

NCT06094920Phase 4Completed

Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial

NCT05138419Not ApplicableTerminated

A Pragmatic Approach to CKD Patient Education

NCT07309094Recruiting

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

NCT06863467Phase 1Completed

Evaluation of the Safety and Tolerability of Gemini in Subjects With Stage 3-4 Chronic Kidney Disease.

NCT05543928Phase 3Terminated

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

NCT06037265Not ApplicableCompleted

PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System

NCT06394544Not ApplicableNot Yet Recruiting

Effects of Brazil Nut Supplementation in Patients With Chronic Kidney Disease Undergoing Conservative Treatment

NCT05489120Not ApplicableRecruiting

Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)

NCT04913272Phase 2SuspendedPrimary

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

NCT05407389Phase 2SuspendedPrimary

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

NCT05153174Phase 1Completed

Study of Sulphoraphane in Chronic Kidney Disease

NCT06495385Active Not RecruitingPrimary

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

NCT05042206Phase 1Completed

Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease

NCT04858854Not ApplicableCompleted

Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2

NCT05624840Completed

Safety and Clinical and Virologic Outcomes in CKD Patients Treated With Nirmatrelvir-ritonavir

NCT05931978Not ApplicableCompleted

Effect of a CKD Dashboard on Patient Activation and Shared Decision Making

NCT04207203Not ApplicableCompletedPrimary

Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study

NCT04336033Not ApplicableUnknown

Validation and Evaluation of a Newly Developed Mobile Diet App

NCT05630729Not ApplicableCompleted

Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management

Scroll to load more

Research Network

Activity Timeline